Metabolic Changes in Children that Received Chemotherapy.

Autor: Soto-Vega E; Faculty of Medicine, Universidad Anáhuac Puebla., Carrillo-Vicente LS; Faculty of Medicine, Universidad Anáhuac Puebla.; Autonomuous Popular University of the State of Puebla., Vázquez JC; Chirstus Muguerza Hospital, North Campus, México city, México., Pérez de Celis Herrero MC; Technologies for Health Laboratoy, FCC, Benemerita Universidad Autonoma de Puebla., Muñoz-Pérez MJ; Faculty of Medicine, Universidad Anáhuac Puebla.; Autonomous Benemerit University of Puebla, Puebla city.
Jazyk: angličtina
Zdroj: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2019 Aug; Vol. 41 (6), pp. 448-451.
DOI: 10.1097/MPH.0000000000001401
Abstrakt: Cancer treatments are associated with short and long-effects. Epidemiological reports have revealed clinical features of metabolic syndrome (MS), obesity or overweight in young cancer survivors. The aim of the study was to examine the prevalence of unhealthy weight status and risk factors associated with MS related to chemotherapy. We study 52 pediatric cancer patients and analyze cholesterol, triglycerides, glycosylated hemoglobin, body mass index, waist circumference (WC), FINDRISC test. All the parameters were analyzed according to the percentile corresponding to sex and age of each child. The data show an important modification in weight, body mass index, and WC as in triglycerides, and cholesterol that could be associated with the development of MS. The variance analysis showed that the WC, triglycerides, and cholesterol are statistically correlated in our population. A follow-up for MS in children cancer survivor should be considered necessary.
Databáze: MEDLINE